Treatment of advanced ovarian cancer: A
β
Bezwoda, W. R.
π
Article
π
1986
π
John Wiley and Sons
π
English
β 395 KB
Fifty-one patients with ovarian cancer were tients with < 2 cm residual disease had sigentered in a randomised trial comparing treat-nificantly higher rate of complete remission rnent with cisplatin + adriamycin + cyclo-than those with > 2 crn residual disease. Carphosphamide (PAC) to cisplatin + 4'